Zobrazeno 1 - 10 of 1 238 pro vyhledávání: '"J. Acar"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Apolipoprotein E5 (Glu212–>Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.
Autor: G Feussner, H Scharnagl, C Scherbaum, J Acar, J Dobmeyer, J Lohrmann, H Wieland, W März
Publikováno v: Journal of Lipid Research, Vol 37, Iss 8, Pp 1632-1645 (1996)
A new apolipoprotein (apo) E variant, apoE5 (Glu212–>Lys) was identified in a Turkish family. The variant was due to a point mutation (CAG–>AAG) at the first nucleotide position of the codon encoding amino acid residue 212 of the mature apoE. The
Externí odkaz: https://doaj.org/article/2a3a95b8cdb24df486c5958e5781511d
Zobrazit plný text záznamu
4
Le secnidazole, un nouveau 5-nitro-imidazolé
Autor: L. Dubreuil, J. Acar, O. Petitjean
Publikováno v: Antibiotiques. 7:177-182
Resume Le secnidazole est un nouveau 5 nitro-imidazole possedant une activite antimicrobienne polyvalente, agissant a la fois comme antiparasitaire et antibacterien. Le secnidazole est employe dans les infections genitales a Trichomonas vaginalis, l
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a712dc60640c0e9484468efe8c2f7a86
https://doi.org/10.1016/s1294-5501(05)80186-4
Zobrazit plný text záznamu
5
Apolipoprotein E5 (Glu212–>Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts
Autor: J. Acar, Winfried März, C Scherbaum, J Dobmeyer, H. Scharnagl, Heinrich Wieland, J Lohrmann, Giso Feussner
Publikováno v: Journal of Lipid Research, Vol 37, Iss 8, Pp 1632-1645 (1996)
A new apolipoprotein (apo) E variant, apoE5 (Glu212–>Lys) was identified in a Turkish family. The variant was due to a point mutation (CAG–>AAG) at the first nucleotide position of the codon encoding amino acid residue 212 of the mature apoE. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8017e8dd1c95d0a77de376f46aebff
https://doi.org/10.1016/s0022-2275(20)39106-9
Zobrazit plný text záznamu
6
A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens
Autor: J. Duval, B. Wiedeman, J. Acar, Richard Wise, Roger Finch, J. Focht, G. Pratts, Adolf Bauernfeind, Ian Phillips, G. Nicoletti, F. Soriano, Gian Carlo Schito
Publikováno v: Journal of Antimicrobial Chemotherapy. 38:627-639
The antibacterial activity of rufloxacin was confirmed against a large number of respiratory and urinary tract pathogens collected in five European countries. In terms of both MIC90 values and percentages of susceptible isolates found, this new quino
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5444674a9058041b847218b9486b070
https://doi.org/10.1093/jac/38.4.627
Zobrazit plný text záznamu
8
Surgical treatment of infective endocarditis
Autor: J. Acar, Michel Pl, T. Rafik, O. Varenne, P. Michaud
Publikováno v: European Heart Journal. 16:94-98
Optimal timing of surgery in infective endocarditis (IE) depends mainly on the haemodynamic tolerance of the patient. Emergency surgery is required in cases of refractory heart failure due to valvular lesions, intracardiac fistulas and high grade car
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc91dee058b1f686b53b71735e3ecf6
https://doi.org/10.1093/eurheartj/16.suppl_b.94
Zobrazit plný text záznamu
9
Native cardiac disease predisposing to infective endocarditis
Autor: P. L. Michel, J. Acar
Publikováno v: European Heart Journal. 16:2-6
Although no epidemiological studies are available to evaluate the exact risk of infective endocarditis complicating native cardiac disease, analysis of data in the literature shows that cardiac disease can be classified into three groups of decreasin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c18041d22af3d0262d17f0b398544251
https://doi.org/10.1093/eurheartj/16.suppl_b.2
Zobrazit plný text záznamu
10
Thrombolytic Therapy: Future Issues
Autor: J Acar, M M Samama
Publikováno v: Thrombosis and Haemostasis. 74:106-110
A considerable amount of work has been devoted to thrombolytic therapy (about 3000 references from 1991 to 1995 in a Medline search). The most important and well established indication of thrombolytic treatment is acute myocardial infarction (MI). Me
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2cb7153cfcf9f37f23ef1cd0136301f
https://doi.org/10.1055/s-0038-1642661
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje